| # | Drug | Count |
|---|---|---|
| 0 | BORTEZOMIB | 9 |
| 1 | CARFILZOMIB | 9 |
| 2 | CISPLATIN | 9 |
| 3 | CYCLOPHOSPHAMIDE | 9 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 9 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 9 |
| 6 | DARATUMUMAB | 9 |
| 7 | DEXAMETHASONE | 9 |
| 8 | DEXAMETHASONE 1.5 MG | 9 |
| 9 | ETOPOSIDE | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MEFENAMIC ACID | 5 | 0.0023 |
| 1 | DONANEMAB-AZBT | 1 | 0.0003 |
| 2 | CARFILZOMIB | 9 | 0.0003 |
| 3 | INFLIXIMAB-DYYB | 1 | 0.0003 |
| 4 | ALISKIREN HEMIFUMARATE | 1 | 0.0002 |
| 5 | ETOPOSIDE | 9 | 0.0001 |
| 6 | DOXORUBICIN HYDROCHLORIDE | 4 | 0.0001 |
| 7 | CISPLATIN | 9 | 0.0001 |
| 8 | BORTEZOMIB | 9 | 0.0001 |
| 9 | EPLERENONE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 9 | 0.0015 |
| 1 | Topoisomerase Inhibitor [EPC] | 9 | 0.0001 |
| 2 | Proteasome Inhibitor [EPC] | 9 | 0.0001 |
| 3 | Bile Acid [EPC] | 1 | 0.0000 |
| 4 | Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 5 | 0.0000 |
| 5 | Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 5 | 0.0000 |
| 6 | Alkylating Drug [EPC] | 9 | 0.0000 |
| 7 | Platinum-based Drug [EPC] | 9 | 0.0000 |
| 8 | CTLA-4-directed Blocking Antibody [EPC] | 1 | 0.0000 |
| 9 | Thalidomide Analog [EPC] | 9 | 0.0000 |